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Abstract. An in-house developed program for real-time reconstruction of motion-induced dose 
errors, DoseTracker, was extended to handle rotational target motion in addition to the 
previously implemented translational motion, and applied offline for prostate VMAT 
treatments. For translational motion, the motion-induced errors of DoseTracker were in good 
agreement with ground truth dose reconstructions performed in a commercial treatment 
planning system. For rotational motion, no ground truth was available, but DoseTracker 
showed that the VMAT dose is highly robust against static interfractional rotations but quite 
sensitive to dynamic intrafraction rotations due to interplay effects between target motion and 
machine motion. 
1.  Introduction 
Image guidance is commonly used in prostate radiotherapy for daily pre-treatment alignment of 
implanted markers with the planned marker positions [1]. The alignment will typically only include 
translational motion although both inter- and intrafractional prostate rotations may be substantial [2]. 
Real-time monitoring of six-degree of freedom (6DoF) prostate motion during radiotherapy delivery 
was recently demonstrated using kilovoltage intrafraction monitoring (KIM) [3]. However, real-time 
motion adaptation by gating or tracking so far only accounts for the translational component of the 
motion [4-5]. The impact of the uncompensated rotational motion is unknown since commercial 
treatment planning systems (TPSs) lack the ability to include rotations. In this study, we extend an in-
house developed fast motion-including dose reconstruction program to 6DoF motion and demonstrate 
real-time use of the program to evaluate the dosimetric effects of dynamic prostate translations and 
rotations during volumetric modulated arc therapy (VMAT) treatments. 
2.  Material and methods 
A software program, DoseTracker, was developed for real-time reconstruction of the dose delivered to 
any set of moving points within a body contour during radiotherapy delivery [6]. DoseTracker first 
calculates the 2D dose distribution in the isocenter plane by convolving the beam aperture with a dose 
kernel and then determines the dose in any point by depth scaling of the isocenter plane dose to the 
point by use of depth dose curves [7]. DoseTracker currently assumes water density.  
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In this study, DoseTracker was extended to pelvic applications and handling of 6DoF internal 
motion. The extended program was applied offline for a prostate cancer patient treated with a dual arc 
VMAT plan created in the Eclipse TPS (Varian Medical Systems). Connection to the accelerator was 
simulated by sending a data stream at 21 Hz to DoseTracker with 6DoF prostate positions and 
accelerator parameters (gantry angle, MLC positions, MU increment, etc.) corresponding to delivery 
of the VMAT plan. In a repeated loop, DoseTracker continuously calculated the dose increment to a 
set of calculation points twice: once with motion and once without motion. These where then used to 
obtain the time-resolved motion-induced dose error for each calculation point. The dose calculations 
were performed for 50,000 calculation points that included the PTV and constituted a subset of the 
original TPS calculation points. The same rigid 6DoF motion was applied to all calculation points 
while the outer body contour was assumed to be static. 
A treatment simulation was first performed with dynamic prostate translations measured with 
implanted electromagnetic transponders [8] to investigate the accuracy of DoseTracker for prostate 
VMAT. A ground truth motion-including dose reconstruction was obtained by a previously validated 
dose reconstruction method that emulates rigid target translations as multiple isocenter shifts in the 
TPS [9] and has been extended for time resolved calculations [10]. A time resolution of 3Hz was used 
corresponding to a dose calculation for every 2° gantry rotation during the simulated VMAT delivery.  
Next, simulations were performed with static prostate rotations about the left-right (LR) axis and 
with dynamic prostate rotations measured with KIM [2]. The dosimetric impact of the rotations was 
quantified as the CTV volume covered by 95% of planned mean CTV dose (V95%). 
 
 
 
Figure 1. (A) Translational prostate motion during 
the two VMAT arcs. (B) Reconstructed dose 
distributions in an axial plane through the prostate 
CTV (green structure) and PTV (red) calculated by 
the Eclipse TPS and DoseTracker with and without 
the motion. The dose color wash shows doses in 
the range 90-110%. The illustrated DoseTracker 
doses were renormalized to the same static mean 
CTV dose as in the TPS. Time resolved doses in 
the numbered dose points are presented in figure 2. 
(C) CTV dose volume histograms for reconstructed 
doses in the Eclipse TPS and in DoseTracker with 
and without translational motion. The DoseTracker 
dose is shown with and without renomalization to 
the same static mean CTV dose as in the TPS.  
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3.  Results and discussion 
DoseTracker performed the motion-including and static dose reconstructions with a mean frequency of 
1.7 Hz, demonstrating that real-time application is feasible. The translational motion included a large 
transient excursion in mainly the anterior direction during the first VMAT arc and a more modest 
continuous drift in the superior-anterior direction during the second arc (figure 1A). DoseTracker 
overestimated the absolute dose level for the prostate with ~10% (figure 1C) due to its simplified 
modelling of the output factor and phantom scatter. Still, the distortion of the dose distribution caused 
by prostate motion during dynamic VMAT delivery (i.e. interplay effects, figure 1B) and the overall 
impact of motion on the CTV dose-volume histogram (figure 1C) were in good agreement with the 
ground truth dose reconstruction by the TPS. The motion-induced reduction in CTV D95 relative to 
the planned dose was 3.6 percent-point for DoseTracker and 3.7 percent-point for the TPS dose 
reconstruction. The time-resolved dose rate and motion-induced dose rate error of DoseTracker in 
selected points in the prostate (figure 1B) were also in good agreement with the TPS ground truth as 
shown in figure 2. Note in particular the large dose deficit in the anterior part of the prostate (Point 1) 
caused by the large anterior excursion of the prostate 6-12 s into the treatment delivery.  
 
 
Figure 2. Top and middle: Dose rate during dual arc 
VMAT delivery as a function of time in Point 1 in 
figure 1B (anterior part of the prostate) as 
reconstructed by DoseTracker (top) and the Eclipse 
TPS (middle) with and without the translational motion 
of figure 1A. Bottom: Cumulative motion-induced 
dose error as a function of time (i.e. cumulative 
difference between the red and black curves in the top 
and middle figures) in the three prostate calculation 
points shown in figure 1B as reconstructed by 
DoseTracker and Eclipse. The dose error is shown in 
percent of the prescribed fraction dose of 2 Gy. 
Static interfractional prostate rotations caused a rotation of the high dose volume relative to the 
prostate, but otherwise kept its shape almost unchanged (figure 3). For the investigated VMAT plan, 
CTV V95% remained high for rotations up to ~10° and then dropped steeply at larger rotations as the 
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prostate moved out of the high dose region (figure 3). The patient-measured dynamic prostate rotation 
was in mean 4.4° (LR axis), 0.5° (superior-inferior axis), and -1.6° (anterior-posterior axis), but it was 
highly dynamic with a maximum of 19° (figure 4A). Interplay effects between the dynamic rotation 
and VMAT delivery markedly distorted the dose distribution and reduced the CTV V95% from 100% 
to 94.9% (figure 4B-C) because of mismatches between the modulated doses received by the prostate 
from different directions. This was in stark contrast to the small dosimetric impact of static rotations, 
which can more easily be mitigated by application of safety margins. 
 
 
 
Figure 3. Top: Examples of dose 
distributions in the sagittal plane 
with static prostate rotations of -25°, 
0°, and 25° about the left-right axis 
(doses above 95% are shown). Note 
that only doses inside the CTV 
(black contour) are relevant since 
the remaining anatomy outside the 
prostate (e.g. bones) does not rotate 
in the same way as the prostate. 
Bottom: CTV V95% as function of 
static left-right prostate rotation. 
 
 
 
Figure 4.  
(A) Patient-measured dynamic 
prostate rotation applied during the 
simulated VMAT treatment.  
(B) Reconstructed dose distribution 
(above 95%) in the sagittal plane as 
planned, with a static rotation equal 
to the mean prostate rotation, and 
with the dynamic rotation of figure 
4A. 
(C) CTV dose volume histogram as 
planned and delivered using both 
the mean prostate rotation and the 
dynamic rotation of figure 4A. 
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4.  Conclusion 
Real-time dose reconstruction including the effects of dynamic 6DoF motion was demonstrated during 
simulated VMAT delivery to the prostate with the in-house developed DoseTracker program. For 
translational motion, a ground truth dose reconstruction could be created in a commercial TPS 
demonstrating ~10% overestimation of the absolute dose level by DoseTracker, but good estimation of 
the motion induced dose errors. Errors in the absolute dose level tend to cancel out when DoseTracker 
calculations with and without motion are compared. For rotational motion, the CTV dose was much 
more susceptible to dynamic prostate rotations than to static rotations. The calculations can be 
integrated with online real-time 6DoF motion monitoring [3] for on-the-fly 6DoF dose reconstruction 
during treatment delivery, e.g. to estimate the residual dose errors after the translational real-time 
corrections currently applied in clinical protocols with prostate gating or MLC tracking [5]. 
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